 Protective efficacy Haemophilus influenzae type polysaccharide conjugate vaccines children months age protective efficacy polyribosylribitol phosphate PRP polyribosylribitol phosphate-diphtheria toxoid PRP-D vaccines children months age case-control study Los Angeles Calif County July July Seventy-nine children invasive Haemophilus influenzae type disease months age controls random-digit telephone methods Cases controls age month disease onset case Seventeen PRP vaccine failures PRP-D vaccine failures weeks vaccination PRP vaccine effective point estimate confidence interval PRP-D vaccine protective confidence interval Adjustment efficacy potential confounding variables results PRP-D vaccine protection PRP vaccine invasive influenzae type disease population